In the wake of its accession to the World Trade Organization, China is changing its legislation to open up its market to foreign competition. This could be an opportunity for increased partnering among biotech companies to exploit complementary technologies.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Related links
Related links
Related links in Nature Research
https://doi.org/10.1038/Nat.Biotechnol.22,1497-1499(2004)
https://doi.org/10.1038/Nat.Biotechnol.22,368(2004)
Related external links
Rights and permissions
About this article
Cite this article
Jia, H., Louët, S. China steps towards international M&A. Nat Biotechnol 23, 159 (2005). https://doi.org/10.1038/nbt0205-159
Issue date:
DOI: https://doi.org/10.1038/nbt0205-159
This article is cited by
-
Japan-China merger puts growth in East Asia first
Nature Biotechnology (2005)
